Our research confirms that EphA2 mediates EBV entry and notably uncovers the opposing roles of IFITM1 and EphA2 in EBV infection, validating their direct interaction through immunofluorescence (IF), co-IP and ELISA. Here, EPHA2 is linked to Epstein-Barr virus infection.